Seeking Alpha

MEI Pharma (MEIP) says Yale School of Medicine's Ayesha Alvero presented data showing the...

MEI Pharma (MEIP) says Yale School of Medicine's Ayesha Alvero presented data showing the company's ME-344 mitichondrial inhibitor "decreased tumor burden and delayed recurrence" in a pre-clinical in vivo recurrence model. The shares rose +2.24% during regular trading.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)